Levosulpiride

DB16021InvestigationalSmall molecule

Levosulpiride is indicated to treat dyspepsia, symptoms of Meniere's syndrome, and second line in the treatment of drug-induced nausea and vomiting. A medication used to treat digestive symptoms, dizziness, and a ringing in the ear.

Chemical structure of Levosulpiride
Mechanism
Curator reviewed
Formula / weight
C15H23N3O4S · 341.43 g/mol (avg)
Also known as
S-(-)-Sulpiride

Resolves to

Compound
UNIIJTG7R315LKCAS23672-07-3ChEMBLCHEMBL267044ChEBI64119
Clinical / RWD
ATCN05AL07
Structure
InChIKeyBGRJTUBHPOOWDU-NSHDSACASA-NSMILESCCN1CCC[C@H]1CNC(=O)C1=CC(=CC=C1OC)S(N)(=O)=O
Targets
Q13639HTR4P14416DRD2

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
693Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
83Marketed productsAcross 2 countries and 20 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Levosulpiride, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In